Olema Oncology Lands Prime South San Francisco Lab Space: A Boost for Breast Cancer Research
Our community, tucked among Marin County’s rolling hills and coastline, has always leaned into innovation, especially in the life sciences. Today, there’s a development just over the Golden Gate Bridge that could send ripples through towns like Sausalito and Mill Valley.
Discover hand-picked hotels and vacation homes tailored for every traveler. Skip booking fees and secure your dream stay today with real-time availability!
Browse Accommodations Now
Olema Oncology, a biopharma company based in San Francisco, just landed a hefty new lease in South San Francisco—a hotspot for biotech. They’re taking a big step forward in their work on targeted therapies for hormone receptor-positive breast cancer, which, let’s be honest, hits way too close to home for many Bay Area families.
Expanding Horizons in South San Francisco
Olema Oncology, known for its clinical-stage drug development, just signed a lease for 38,176 square feet at 365 Oyster Point Boulevard. This spot is right in the Phase II building of Kilroy’s growing Oyster Point life sciences campus—a place that’s quickly turning into a real epicenter for the field.
The seven-year lease kicks off in September. This gives Olema a major boost in lab and office space, which they’ll need as research and development ramps up.
It’s not just about more room—it’s about building the infrastructure to speed up their oncology pipeline. For a team chasing new treatments, having the right space for careful research is everything.
I can picture Olema’s scientists, maybe even some who live in Tiburon or Belvedere, finding real inspiration in this new setup. It feels like the kind of place where big discoveries could actually happen.
A Booming Life Science Market Fueled by Demand
The ink’s barely dry on this lease, and already the news is buzzing with proof of stubbornly high demand for life-science real estate—especially in the South San Francisco area. It’s wild how this trend keeps picking up steam.
We’ve watched this closely, and honestly, it’s exciting to see innovation and investment pouring into the Bay Area. Not only does it boost San Francisco and South San Francisco, but it also supports the expertise and talent that thrives in Marin communities, from Larkspur to Mill Valley.
CoStar Research reported this transaction, showing just how fast-paced the biotech sector can be. The industry may cluster in certain places, but it leans on a skilled workforce and a supportive ecosystem that stretches across the whole region.
The fact that CoStar flagged this as exclusive for subscribers says a lot about the fierce competition and the buzz around these kinds of deals.
JLL executives Scott Miller, Mark Bodie, and Toss Vallentine played a huge role in making this lease happen. They really know the life science real estate market, and their ability to connect Olema Oncology with this space says it all.
For those of us in Marin County, this news is a solid reminder of the big scientific leaps happening practically in our backyard. It’s hard not to feel a bit of pride about the interconnectedness of our region.
We’ll definitely keep an eye on Olema Oncology’s progress. Their work touches so many lives and stands out as a real beacon of hope in the fight against breast cancer.
Here’s wishing them the best as they settle into their new home and keep pushing their research forward.
Here is the source article for this story: News | Olema Oncology inks lease at South San Francisco life sciences campus
Find available hotels and vacation homes instantly. No fees, best rates guaranteed!
Check Availability Now